A comparative randomized study for the evaluation of the overlaying effect of Selegiline or Zonisamide over Levodopa in Parkinson's disease

Trial Profile

A comparative randomized study for the evaluation of the overlaying effect of Selegiline or Zonisamide over Levodopa in Parkinson's disease

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2016

At a glance

  • Drugs Selegiline (Primary) ; Zonisamide (Primary) ; Levodopa
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top